Revenue: The sum of all revenue fields included for a company's operating activities.
Galmed Pharmaceuticals Ltd. (GLMD) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-4.82M |
|
-- |
|
-- |
|
$3.04M |
|
$-3.04M |
|
$-1.78M |
|
$-4.82M |
|
$-2.88M |
|
$-4.82M |
|
$-4.82M |
|
$-4.82M |
|
$-2.88M |
|
$-3.04M |
|
$-3.05M |
|
4.31M |
|
4.31M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$18.63M |
|
-- |
|
-- |
|
$18.63M |
|
$2.85M |
|
-- |
|
-- |
|
$2.85M |
|
$15.78M |
|
$15.78M |
|
$15.78M |
|
6.58M |
|
| Cash Flow Statement Financials | |
$-6.32M |
|
$-3.38M |
|
$9.03M |
|
$4.77M |
|
$4.11M |
|
$-0.66M |
|
$0.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.53% |
|
-30.53% |
|
-25.87% |
|
-30.53% |
|
$2.40 |
|
$-1.46 |
|
$-1.46 |
|